SpaceX Stock Soared on Day One. Is the Stock a Buy at $2 Trillion?

SpaceX’s post-IPO trading has been highly volatile, rising above $160 on day one before falling back to below $155 per share and trimming its valuation from more than $2.7 trillion to about $2 trillion. The article argues that at roughly 125x sales, SpaceX may be attractive for some investors but that alternatives like Rocket Lab or Nvidia could offer more appealing risk/reward. Overall, the piece is opinion-driven commentary rather than new company-specific fundamentals.

Analysis

The real signal here is not the headline move in the private-share print, but the market’s willingness to reprice duration and narrative risk in a single session. When a highly promoted, illiquid asset can gap from euphoria to a 15% drawdown within days, it tells you the marginal buyer is momentum-driven and price-insensitive — a setup that often spills over into adjacent high-multiple growth and pre-profit names. That matters more for NVDA than the space theme itself: if the market starts demanding proof-of-earnings rather than TAM rhetoric, the first beneficiaries are the profitable AI infrastructure providers, while the second-order losers are the “AI-adjacent” companies still selling optionality instead of cash flow.

The competitive read-through is more interesting than the direct trade. The article frames Rocket Lab as the cleaner pure-play, which is directionally right, but the deeper point is that capital will likely rotate toward companies with narrower scope, easier underwriting, and visible path-to-cash — not necessarily the cheapest story. That supports NVDA as the default AI monetization vehicle, but also creates a valuation ceiling for anything with similar exposure but weaker fundamentals, because investors will benchmark every AI spend against NVDA’s earnings power and not against speculative platform narratives.

Contrarian takeaway: the move may be under-discounting how quickly private-market valuation resets can infect public comps. If SpaceX-style pricing is fading, late-stage venture and secondary-market AI/space exposure could see bid-side thinning over the next 1-2 quarters, particularly if rates stay sticky and secondary liquidity remains selective. The risk is that this is still just one volatile print in an opaque asset, so the best response is not to short the story blindly, but to express skepticism through names where multiple compression is least painful and balance sheets are strongest.

Key Decisions for Investors

• Overweight NVDA versus high-multiple, pre-profit AI proxies for the next 1-3 months; use any 5-8% market pullback to add, with a favorable risk/reward because earnings power should defend multiple compression better than narrative names.
• Avoid initiating new longs in speculative private-to-public translation trades for 2-4 weeks; the implied message is that secondary pricing can rebase abruptly, so patience has a better expected value than chasing momentum.
• If seeking a relative-value expression, pair long NVDA / short a basket of unprofitable AI-adjacent growth names with >20x sales and no near-term free cash flow; target a 10-15% spread widening if the market rotates toward profitability.
• For investors wanting space exposure, prefer RKLB over any headline-driven, valuation-extended space basket on pullbacks; the cleaner single-thread story should hold up better if capital markets demand clearer operating milestones.
• Use short-dated downside hedges on crowded growth benchmarks over the next 30-45 days; the setup favors a volatility spike if the market starts repricing speculative duration assets beyond this one name.